These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 4653403)

  • 21. [Relation between the physiological activity of oxytocin & the state of its disulfide bonds].
    AUDRAIN L; CLAUSER H
    Biochim Biophys Acta; 1958 Oct; 30(1):191-2. PubMed ID: 13584417
    [No Abstract]   [Full Text] [Related]  

  • 22. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of oxytocin HYNIC derivatives as potential diagnostic agents for breast cancer.
    Miranda-Olvera AD; Ferro-Flores G; Pedraza-López M; de Murphy CA; De León-Rodríguez LM
    Bioconjug Chem; 2007; 18(5):1560-7. PubMed ID: 17665873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of oxytocin analogues with replacement of sulfur by carbon gives potent antagonists with increased stability.
    Stymiest JL; Mitchell BF; Wong S; Vederas JC
    J Org Chem; 2005 Sep; 70(20):7799-809. PubMed ID: 16277299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]-OT and [dPen1,Pen6, 5-tBuPro7]-OT by NMR, Raman, CD spectroscopy and molecular modeling.
    Bélec L; Blankenship JW; Lubell WD
    J Pept Sci; 2005 Jul; 11(7):365-78. PubMed ID: 15641022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of the disulfide bridge in the Rieske iron-sulfur protein allows assembly of the [2Fe-2S] cluster into the Rieske protein but damages the ubiquinol oxidation site in the cytochrome bc1 complex.
    Merbitz-Zahradnik T; Zwicker K; Nett JH; Link TA; Trumpower BL
    Biochemistry; 2003 Nov; 42(46):13637-45. PubMed ID: 14622010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between disulfide reduction and conformational unfolding in bovine pancreatic trypsin inhibitor.
    Ma LC; Anderson S
    Biochemistry; 1997 Mar; 36(12):3728-36. PubMed ID: 9132026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of disulfide bonds in the two-disulfide intermediates in the regeneration of bovine pancreatic ribonuclease A: further insights into the folding process.
    Volles MJ; Xu X; Scheraga HA
    Biochemistry; 1999 Jun; 38(22):7284-93. PubMed ID: 10353840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Isoleucine-oxytocin and deamino-2-isoleucine-oxytocin: their synthesis and some of their pharmacologic activities.
    Branda LA; Hruby VJ; Du Vigneaud V
    Mol Pharmacol; 1967 May; 3(3):248-53. PubMed ID: 6068341
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhanced microwave-assisted method for on-bead disulfide bond formation: synthesis of alpha-conotoxin MII.
    Galanis AS; Albericio F; Grøtli M
    Biopolymers; 2009; 92(1):23-34. PubMed ID: 19003899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of glutaredoxin and protein disulfide isomerase on the glutathione-dependent folding of ribonuclease A.
    Ruoppolo M; Lundström-Ljung J; Talamo F; Pucci P; Marino G
    Biochemistry; 1997 Oct; 36(40):12259-67. PubMed ID: 9315864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthesis of [1,6-bis(L-alpha, beta-diaminopropionic acid) oxytocin].
    Wu K; Weng L; Zheng H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):818-21. PubMed ID: 17002115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of native disulfide bonds in endothelin-1. Structural evidence for the involvement of a highly specific salt bridge between the prosequence and the endothelin-1 sequence.
    Aumelas A; Kubo S; Chino N; Chiche L; Forest E; Roumestand C; Kobayashi Y
    Biochemistry; 1998 Apr; 37(15):5220-30. PubMed ID: 9548753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of the parallel dimer of oxytocin.
    Aanning HL; Yamashiro D
    J Am Chem Soc; 1970 Aug; 92(17):5214-6. PubMed ID: 5432665
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of oxytocin: suppression of dimer formation.
    Wälti M; Hope DB
    Experientia; 1973 Apr; 29(4):389. PubMed ID: 4708316
    [No Abstract]   [Full Text] [Related]  

  • 36. Solid phase synthesis of oxytocin.
    Bayer E; Hagenmaier H
    Tetrahedron Lett; 1968 Mar; 17():2037-9. PubMed ID: 5646943
    [No Abstract]   [Full Text] [Related]  

  • 37. Removal of the N alpha-benzyloxycarbonyl group from cysteine-containing peptides by catalytic hydrogenolysis in liquid ammonia, exemplified by a synthesis of oxytocin.
    Kuromizu K; Meienhofer J
    J Am Chem Soc; 1974 Jul; 96(15):4978-81. PubMed ID: 4854100
    [No Abstract]   [Full Text] [Related]  

  • 38. 7-D-proline-oxytocin and its deamino analog. Diastereoisomers of oxytocin and deamino-oxytocin.
    Ferraro JJ; du Vigneaud V
    J Am Chem Soc; 1966 Aug; 88(16):3847-50. PubMed ID: 5916375
    [No Abstract]   [Full Text] [Related]  

  • 39. An alternative synthesis of [7-(thiazolidine-4-carboxylic acid)]-oxytocin.
    Barber M; Jones JH
    Int J Pept Protein Res; 1977; 9(4):269-71. PubMed ID: 852929
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthetic analogues of oxytocin: an approach to problems of hormone action.
    Rudinger J
    Proc R Soc Lond B Biol Sci; 1968 May; 170(1018):17-26. PubMed ID: 4384879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.